Literature DB >> 1036465

Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system.

K D Herbst, M P Corder, G R Justice.   

Abstract

Primary lymphoma of the central nervous system (CNS) is extremely rare. A case of mixed histiocytic lymphocytic lymphoma of the CNS that initially occurred in the spinal cord is reported. Multicentric recurrence following radiotherapy was successfully treated with intrathecal methotrexate and the patient remains free of disease after 4 years. The role of intrathecal methotrexate as alternative therapy following irradiation failure is discussed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1036465     DOI： 10.1002/1097-0142(197610)38:4<1476::aid-cncr2820380405>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Biology and treatment of primary central nervous system lymphoma.

Authors:  Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

2.  PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.

Authors:  S Dent; L Eapen; A Girard; H Hugenholtz; V DaSilva; D J Stewart
Journal:  J Neurooncol       Date:  1996-04       Impact factor: 4.130

3.  Regional chemotherapy in an experimental model of Wilms' tumor in rats.

Authors:  P M Andrews; C L Johnson
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Computed tomography of malignant lymphoma of the brain.

Authors:  S Holtås; U Nyman; S Cronqvist
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

Review 6.  Primary brain lymphoma. A brief review of clinical aspects and management.

Authors:  K Sharma; N Rastogi; R Srivastva; V K Jain; S Hukku
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

Review 7.  The therapy of primary brain lymphoma.

Authors:  F H Hochberg; J S Loeffler; M Prados
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

8.  Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data.

Authors:  A Boiardi; A Silvani; S Valentini; A Salmaggi; A Allegranza; G Broggi
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

9.  Intramedullary non-Hodgkin's lymphoma of the spinal cord: a case report and literature review.

Authors:  A C McDonald; J A Nicoll; R Rampling
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.